Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc. (FOLD)

Delisted
27 Apr 2026
NASDAQ (NMS) NASDAQ (NMS)
$
14. 49
0
0%
Pre Market
$
14. 50
+0.01 +0.069%
4.55B Market Cap
- P/E Ratio
- Div Yield
5.29M Volume
-0.45 Eps
$ 14.49
Previous Close
Day Range
14.49 14.49
Year Range
5.51 14.5
Want to track FOLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Amicus Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
635 $6,965.38 $9,182 $2,216.62 31.82%
JM
John Malone Amundi
16,755 $242.28 $242.28 - -
Bobby Adusumilli
Bobby Adusumilli SJS Investment Consulting Inc.
48 $0.68 $0.68 - -
Tricia Peterson
Tricia Peterson Mesirow Institutional Investment Management Inc.
89,382 $975.05 $1,052.93 $77.88 7.99%
Kevin Kroskey
Kevin Kroskey True Wealth Design LLC
893 $7,304.11 $7,036.97 -$267.14 -3.66%
Mathieu Cornu
Mathieu Cornu Pictet Asset Management Holding SA
893,901 $7.06M $7.06M - -
MC
Megan Claucherty Kodai Capital Management LP
605,110 $4.94M $4.94M - -
Angela Mari
Angela Mari Abich Financial Wealth Management LLC
10,779 $84,939 $84,939 - -
VT
Vincent Tortorella Point72 (DIFC) Ltd
34,876 $269,748.33 $284,588.33 $14,840 5.5%
Charles Hillier
Charles Hillier Cibra Capital Ltd.
1.69M $24.36M $24.03M -$324,909.42 -1.33%